The Covid-19 vaccine will not cure the global economy


Most experts believe that it is unlikely – but not impossible – that the vaccine will be ready before the US election. But despite having at least seven candidates in the three-phase test, it is likely that at least one successful vaccine will come out in the coming months. Pharmaceutical companies are also scrambling to develop effective treatments for the disease.

The effective vaccine has been shown to be a magic bullet that will allow the global economy to quickly turn into gear. However, there are reasons why recovery may be slow: the vaccine is usually not 100% effective and there will be a limited number of doses to be given. Distribution can be a problem, between both countries and between them. Even if those challenges are overcome, some people may choose not to get vaccinated.

Neil Shearing, group chief economist at Capital Economics, wrote in a recent research note that once the vaccine is certified, there are many potential consequences for the economy. And believing it would be wrong, a vaccine would change the economic outlook for the coming year.

“At one end of the spectrum lies a highly effective vaccine that is quickly produced and distributed. On the other side is a less effective vaccine that faces significant production and distribution challenges and will have a relatively short supply in 2021.” “In most of the intervening circumstances, in all probable circumstances, the inclusive measures, including social distance and restrictions on some foreign travel, will remain in place for the foreseeable future.”

The first challenge is the vaccine itself: The World Health Organization has said it would choose a vaccine that is at least 70% effective, but it has set its minimum threshold for the Covid-19 vaccine at 50%. This means that every other person vaccinated may still be at risk of infection which will prevent them from working and spending money.

Supply is another important factor: According to Shearing, developer figures suggest that 1 billion doses may be available this year, with another 7 billion ready for distribution in 2021. But, this number assumes that multiple vaccines have been approved, and supply could be significantly reduced. Special needles and syringes will be needed to administer this vaccine, but hands are not enough in countries including the United States. There is also a global shortage of glass vials to cope with. The WHO does not expect comprehensive vaccinations until the middle of next year, a spokesman said Friday.

After all, many people are reluctant to get vaccinated: According to a survey by Deutsche Bank, only 1% of people in France say they would consider getting vaccinated if given a certificate in the next six months, while 0% to 75% of Germans, Italians and Spaniards say the same is true. Is. , Brits and Americans. In Europe, half the people agreed that “the vaccine is safe,” the bank said in a research note last week.

“From the perspective of the global economy, the issue is not as simple as whether there is a vaccine or not.”

Market understanding: Due to the enthusiasm of retail investors in biotech and pharma stocks like Moterna, there has been an increase this year on the promise of developing a potential vaccine. Traders who are investing in stocks on platforms like Robinhood can burn if trials do not come or distribution challenges arise.

‘Mulan’ may have to conquer the world

The studio is hoping international revenue could help sustain Hollywood Hollywood as the United States struggles to regain its footing after a smoked coronavirus response.

With theater performances in the United States now only life is back, other countries – especially China, but also Europe’s income is the most closely watched barometer for the industry.

My colleagues Frank Palota and Brian Lowry have reported that even the United States is not part of Disney’s theater strategy for this week’s “Mulan”.

After multiple delays, the studio is releasing a live-action remake of just the 1998 animated classic on its new streaming service Disney + in the United States on Friday. It will also open in theaters in a handful of international markets.

The idea of ​​opening a blockbuster like “Mulan” in foreign theaters, not just in the United States, was unthinkable just a few months ago. The move could be a “transformative” moment for Hollywood, according to Yanne Caucas, an associate professor at the University of Virginia and author of “Hollywood Made in China.”

“The U.S. is the world’s largest box office fee market. It will not be able to retain the title this year if covid sanctions continue,” Coca said. “This could be a hurdle if the U.S. is able to return to its previous position, or it could be a hurdle point.”

Another potential blockbuster – “Tenet” – entered China on Friday. The country’s cinemas reopened in July, a month before the United States. (“Tenet” is produced by Warner Bros., which, like CNN, owns WarrenMedia.)

The epic of war “The I So So So.” Including, Chinese movie theaters have already had some success since reopening. The film has grossed last 277 million in China since its release last month, making it the third best-performing movie of the year, according to Box Office Fish Mojo.

Now the next

Monday: US markets were closed

On tuesday: Slack and Lulemon earnings

Wednesday: China inflation data; Bank of Canada meeting; Game Stop Earnings

Thursday: U.S. Early unemployment claims; Chevy and Peloton earnings; European Central Bank meeting

Friday: US inflation data; Kroger earnings

.